Garelius, H K G, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X, Bagguley, Timothy Charles orcid.org/0000-0002-6150-3467 et al. (20 more authors) (2022) Erythropoietin stimulation agents significantly improves outcome in lower risk MDS. HemaSphere. S168. pp. 69-70. ISSN: 2572-9241
Abstract
The EUMDS Registry started in 2008 as a prospective, non-interventional longitudinal study, enrolling newly diagnosed patients with IPSS low or intermediate-1 MDS from 16 European countries and Israel.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. |
| Dates: |
|
| Institution: | The University of York |
| Academic Units: | The University of York > Faculty of Sciences (York) > Health Sciences (York) |
| Depositing User: | Pure (York) |
| Date Deposited: | 28 Jun 2022 08:50 |
| Last Modified: | 20 Sep 2025 01:48 |
| Published Version: | https://doi.org/10.1097/01.hs9.0000843564.40783.b4 |
| Status: | Published |
| Refereed: | Yes |
| Identification Number: | 10.1097/01.hs9.0000843564.40783.b4 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:188510 |
Download
Filename: S168_ERYTHROPOIETIN_STIMULATION_AGENTS.69.pdf
Description: S168__ERYTHROPOIETIN_STIMULATION_AGENTS.69
Licence: CC-BY 2.5

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)